Bioverativ Inc (BIVV):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Bioverativ Inc (BIVV) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7186
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technology for the treatment of hemophilia A; and Alprolix, which comprises recombinant coagulation factor IX engineered using Fc fusion technology for the treatment of hemophilia B. The company’s pipeline encompasses investigational candidates for the treatment of cold agglutinin disease, hemophilia A, beta thalassemia sickle cell disease, hemophilia B, and Sickle cell disease. Bioverativ sells its products in the US, the European Union (EU), New Zealand, Canada, Australia, Japan, Switzerland, Iceland, Liechtenstein, and Norway. Bioverativ is headquartered in Waltham, Massachusetts, the US.

Bioverativ Inc (BIVV) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Bioverativ Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bioverativ Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bioverativ Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bioverativ Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Bioverativ Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Bioverativ Inc, Medical Equipment, Deal Details 10
Venture Financing 10
True North Therapeutics Raises USD45 Million in Series D Financing 10
Partnerships 11
Bioverativ and Invicro Enter into Agreement 11
R-Health Enters into Agreement with Bioverativ 12
Acquisition 13
Sanofi Acquires Bioverativ for USD11.5 Billion in Tender Offer 13
Bioverativ Therapeutics Acquires True North Therapeutics 15
Bioverativ Inc – Key Competitors 16
Bioverativ Inc – Key Employees 17
Bioverativ Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Feb 13, 2018: Bioverativ Reports Fourth Quarter and Full Year 2017 Performance 19
Oct 26, 2017: Bioverativ Reports Third Quarter 2017 Performance 21
Aug 02, 2017: Bioverativ Reports Second Quarter 2017 Performance 23
May 03, 2017: Bioverativ Reports First Quarter 2017 Results 25
Corporate Communications 27
May 15, 2017: Bioverativ Appoints Geno J. Germano to Company’s Board of Directors 27
Apr 10, 2017: Bioverativ Appoints Tim Harris Executive Vice President, Research and Development 28
Other Significant Developments 29
Aug 24, 2017: Bioverativ and Invicro Form Novel, Advanced Imaging Collaboration Focused on Improving Management of Joint Health in People with Hemophilia 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Bioverativ Inc, Medical Equipment, Key Facts, 2017 2
Bioverativ Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bioverativ Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bioverativ Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Bioverativ Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bioverativ Inc, Deals By Market, 2012 to YTD 2018 8
Bioverativ Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
True North Therapeutics Raises USD45 Million in Series D Financing 10
Bioverativ and Invicro Enter into Agreement 11
R-Health Enters into Agreement with Bioverativ 12
Sanofi Acquires Bioverativ for USD11.5 Billion in Tender Offer 13
Bioverativ Therapeutics Acquires True North Therapeutics 15
Bioverativ Inc, Key Competitors 16
Bioverativ Inc, Key Employees 17
Bioverativ Inc, Other Locations 18
Bioverativ Inc, Subsidiaries 18

List of Figures
Bioverativ Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bioverativ Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bioverativ Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bioverativ Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bioverativ Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Bioverativ Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Bioverativ Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Bioverativ Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Bioverativ Inc (BIVV):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Virgin Group Ltd.:企業の戦略・SWOT・財務情報
    Virgin Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Virgin Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • 84 Lumber Company:企業の戦略・SWOT・財務情報
    84 Lumber Company - Strategy, SWOT and Corporate Finance Report Summary 84 Lumber Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Chemical Company of Malaysia Berhad (CCM)-製薬・医療分野:企業M&A・提携分析
    Summary Chemical Company of Malaysia Berhad (CCM) is an industrial and specialty chemicals company. Its core business activities include provision of pharmaceuticals and healthcare products; chemical products and applications; and polymer coatings and applications. The company’s product range find a …
  • Cheniere Energy Inc (LNG):企業の財務・戦略的SWOT分析
    Cheniere Energy Inc (LNG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hamilton Thorne Ltd (HTL):企業の財務・戦略的SWOT分析
    Summary Hamilton Thorne Ltd (Hamilton Thorne) is a medical equipment company that offers precision laser devices and advanced image analysis systems. The company's products include clinical lasers, animal and research sperm analysis products, research lasers, clinical sperm analysis products, sperm …
  • Alnylam Pharmaceuticals Inc (ALNY):企業の財務・戦略的SWOT分析
    Alnylam Pharmaceuticals Inc (ALNY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • OpGen Inc (OPGN)-医療機器分野:企業M&A・提携分析
    Summary OpGen Inc (OpGen) is a molecular diagnostics company that harnesses genomic analysis and bioinformatics to prevent the threat of antibiotic resistance and multi drug resistant organisms (MDROs). The company’s clinical laboratory services include high resolution microbial sequence analysis, s …
  • Korber AG:企業の戦略・SWOT・財務情報
    Korber AG - Strategy, SWOT and Corporate Finance Report Summary Korber AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Aernnova Aerospace, S.A.:企業の戦略・SWOT・財務情報
    Aernnova Aerospace, S.A. - Strategy, SWOT and Corporate Finance Report Summary Aernnova Aerospace, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Equinor ASA Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Equinor ASA Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Equinor ASA (Equinor), formerly Statoil ASA, is an energy company. It focuses mainly on the exploration, development and production of crude oil and natural gas on the Norwegian Continental Shelf (NCS). …
  • KDDI Corporation (9433):企業の財務・戦略的SWOT分析
    KDDI Corporation (9433) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Momenta Pharmaceuticals Inc (MNTA):製薬・医療:M&Aディール及び事業提携情報
    Summary Momenta Pharmaceuticals Inc (Momenta) is a biotechnology company which specializes in the structural analysis, characterization, and design of complex pharmaceuticals. The company’s products include Glatopa; and Enoxaparin Sodium Injection. Its pipeline portfolio encompasses candidates to su …
  • Batory Foods, Inc.:企業の戦略・SWOT・財務情報
    Batory Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Batory Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Asarina Pharma AB-製薬・医療分野:企業M&A・提携分析
    Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB is a drug development company that concentrates on the discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cycl …
  • Woori Bank:戦略・SWOT・企業財務分析
    Woori Bank - Strategy, SWOT and Corporate Finance Report Summary Woori Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • University of Texas MD Anderson Cancer Center:医療機器:M&Aディール及び事業提携情報
    Summary University of Texas MD Anderson Cancer Center (MD Anderson) is one of the leading cancer care centers in the US. It is one of the three original comprehensive cancer care centers designated by the National Cancer Act of 1971 in the US and is affiliated to University of Texas Health. MD Ander …
  • Clark Construction Group LLC:企業の戦略的SWOT分析
    Clark Construction Group LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • BlackRock Inc:企業の戦略・SWOT・財務情報
    BlackRock Inc - Strategy, SWOT and Corporate Finance Report Summary BlackRock Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ineos Group AG-石油・ガス分野:企業M&A・提携分析
    Summary Ineos Group AG (Ineos) is a chemical company, which manufactures and sells petrochemicals, specialty chemicals and oil products. The company’s products include engineering thermoplastic resins, chlor-alkali chemicals, PVC products, films and compounds; and melamine resins for coating, specia …
  • International Finance Corporation:企業の戦略的SWOT分析
    International Finance Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆